CLX

A 104% Payout Ratio on a 47-Year Raiser

In the snapshot behind this site, Clorox (CLX) shows a payout ratio of 104.0% — the company is distributing slightly more than it earned over the trailing twelve months. On most stocks that reading is worth stopping for. On this one it is close to meaningless, and Clorox's own filings are what demonstrate it. Across the three most recent completed fiscal years, the same dividend policy produced payout ratios of roughly 393%, 213%, and 75%. The dividend rose 3.4% over that span. The ratio moved by a factor of five.

That gap is the subject here: not whether 104% is high, but what a ratio can tell you when its denominator swings this violently.

The Arithmetic, and Where It Breaks

The formula is not in dispute:

Payout ratio = trailing annual dividend ÷ trailing 12-month earnings per share

For Clorox in this snapshot, that is roughly $5.00 in trailing dividends against $4.81 of trailing GAAP earnings per share — 104%. The most recent quarterly payment was $1.24, paid on a quarterly schedule; that last payment and the trailing 12-month figure are separate measures and are not interchangeable.

Both inputs are facts. The problem is that only one of them is stable. Dividends are set by a board and changed deliberately, usually once a year, usually by a small amount. GAAP earnings per share absorb impairments, restructuring charges, legal settlements, and tax adjustments in whichever quarter they land, then carry them for four quarters before they roll out of the trailing window. When the denominator does the moving, the ratio stops describing the dividend and starts describing the accounting year.

Six Fiscal Years of Clorox's Denominator

Clorox filed its fiscal 2026 annual report with the SEC on August 7, 2026, four days after releasing fourth-quarter results. The diluted earnings-per-share figures in its filings on SEC EDGAR show how unusual this company's earnings line is: $7.36 in fiscal 2020, $5.58 in 2021, $3.73 in 2022, $1.20 in 2023, $2.25 in 2024, and $6.52 in 2025. A greater than fivefold range, in a household-products business whose sales do not behave anything like that.

Set the declared dividend beside it. Figures below combine Clorox's SEC filings for completed fiscal years with the site snapshot dated 2026-08-09 for the trailing-twelve-month row.

Fiscal year (ends June 30)	Diluted EPS	Declared dividend	Implied payout
FY2023	$1.20	$4.72	~393%
FY2024	$2.25	$4.80	~213%
FY2025	$6.52	$4.88	~75%
Trailing 12M (snapshot)	$4.81	~$5.00	104%

Read down the dividend column and almost nothing happens: three annual increases totalling sixteen cents. Read down the payout column and the company appears to go from catastrophically overextended to comfortably covered and back to stretched, without the board ever doing anything unusual. A reader who saw only the FY2023 ratio would have concluded the dividend was funded almost four times over from something other than profit. A reader who saw only FY2025 would have called it well covered. Neither reader would have learned much about Clorox.

What the Yield Adds

The yield tells a cleaner story because its denominator is a market price rather than an accounting result. Clorox yields 4.76% in this snapshot, against a five-year average of 3.54% and a ten-year average of 2.98%. That places the current yield about 34% above its own five-year norm, and our screen classifies the stock as Undervalued on that basis — a comparison of today's yield to its own history, described on the methodology page, not a judgment about the business.

A yield rises either because the dividend grew or because the price fell. Clorox's dividend grew by low single digits. So the yield is mostly reporting a repriced stock, and the 47-year raise streak — against a median of 32 years across the Dividend Aristocrats tracked here — is the part of the record that has not wobbled.

The Case Against Reading It This Way

The argument above can be pushed too far, in two directions.

First, an unstable denominator does not mean the ratio is always wrong. It means it is noisy in both directions. The FY2025 reading of about 75% flattered Clorox exactly as much as the FY2023 reading maligned it. Anyone using this article's logic to dismiss a high payout should be equally willing to dismiss a reassuring low one. That cuts against the comfortable conclusion.

Second, the volatility itself carries information. Six fiscal years with EPS between $1.20 and $7.36 is not merely an accounting artifact to be waved away — repeated large charges are a real pattern, and a business that keeps taking them has something recurring going on beneath the label "one-time." The honest position is that the payout ratio is the wrong instrument for measuring it, not that there is nothing to measure.

It is also worth being clear about what this site does not publish. The measure that would actually settle the question — dividends against free cash flow, which is far less sensitive to non-cash charges — is not in our dataset. Anyone who wants that number has to take it from the cash flow statement in the filings directly.

What Would Change the Reading

Three things, in rough order of how much they would matter.

A change in the dividend itself is the only one that alters the numerator, and it is the one to watch: a slower increase, or a pause, would say more in a single announcement than any ratio has said in six years. Second, the trailing window rolling past a large charge mechanically resets the ratio without any news at all — the timing effect described in When the Payout Ratio Breaks. Third, forward earnings estimates in this snapshot sit at $6.36 per share against $4.81 trailing; if reported results move toward that level, the same unchanged dividend would print a payout near 79%.

Price, yield history, and the ex-dividend schedule refresh daily on the Clorox (CLX) data page, and the screener shows where its payout and yield sit against the rest of the tracked universe. For the general case of how to read this metric and where it fails, The Payout Ratio covers the mechanics.

Disclaimer: This is informational only and not financial advice. Site figures reflect the snapshot dated 2026-08-09 and move with the market; fiscal-year figures are from Clorox's SEC filings. Investing carries risk of loss, including loss of principal.